Anti-Human IL-3 Rα (CD123)

Leinco Technologies
Product Code: LEI-I-651
Product Group: Primary Antibodies
CodeSizePrice
LEI-I-651-25ug25 ug£398.00
Quantity:
LEI-I-651-100ug100 ug£671.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 32703
Regulatory Status: RUO
Target Species: Human
Applications:
  • Flow Cytometry
  • Immunocytochemistry (ICC)
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
  • Mass Cytometry (CyTOF)
  • Neutralisation
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antibody can be stored desiccated at -20°C to -70°C for up to twelve months. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles. No detectable loss of activity was observed after six months.

Further Information

Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Formulation:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Immunogen:
Purified Recombinant Human IL-3 Rα (Accession # P26951)
Long Description:
Interleukin 3 receptor alpha (IL3RA), also known as CD123 (Cluster of Differentiation 123), is a type I transmembrane protein that is expressed on the large majority of progenitor cells. IL-3R alpha function can be defined by the activity of its ligand interleukin-3. IL-3 is a multipotent cytokine that promotes the development of hemopoietic progenitors into cells of the erythroid, myeloid and lymphoid lineages.1 CD123 may be a promising strategy for the preferential ablation of acute myelogenous leukemia (AML) cells.2
Target:
IL-3 R alpha

References

1. Garnache-Ottou, F. et al. (2015) Haematologica. 100(2):223-302. Phillips, GL. et al. (2000) Leukemia 14: 1777

Related Products

Product NameProduct CodeSupplier 
Recombinant Mouse IL-3 RαLEI-I-598Leinco Technologies Summary Details
Anti-Mouse IL-3 RαLEI-I-618Leinco Technologies Summary Details
Anti-Mouse IL-3 Rα (CD123)LEI-I-719Leinco Technologies Summary Details